Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 23,809-23,820 of 23,847

CompletedNCT00821444

Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

View study

CompletedNCT01293825

Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among people with Bipolarity (Zip Ad)

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

In Cleveland

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity

View study

CompletedNCT00239109

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bilbao

SchizophreniaDrugFrom 18 Years to 70 Years

Countries: Spain
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

View study

WithdrawnNCT00786318

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

This summary needs review. Please check the official study record and contact the research team for details.

In Washington D.C.

SchizophreniaBehavioralFrom 18 Years to 100 Years

Countries: United States
Sponsor: George Washington University
Condition: Schizophrenia

View study

CompletedNCT00340379

Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States, Egypt, India
Sponsor: Duke University
Condition: Depression, Schizophrenia

View study

CompletedNCT03584542

ZOlpidem and the stRengthening of pRescription regulatiOn

This summary needs review. Please check the official study record and contact the research team for details.

In Nantes

AddictionOtherOver 18 Years

Countries: France
Sponsor: Nantes University Hospital
Condition: Addiction

View study

CompletedNCT00221442

Zonegran in the Treatment of Binge Eating disorders Associated With Obesity

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati

Eating disordersDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Eating disorders

View study

CompletedNCT01685996

Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

View study

TerminatedNCT01566370

Zonisamide for Heavy Drinkers With Bipolarity

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can work better when mental health difficulties overlap with substance use.

In West Haven

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Bipolarity

View study

CompletedNCT01847469

Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In West Haven

PTSDBehavioralFrom 21 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: PTSD

View study

WithdrawnNCT03376139

Zonisamide Outpatient Study

This summary needs review. Please check the official study record and contact the research team for details.

In Houston

PTSD, AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Condition: PTSD, Addiction

View study

CompletedNCT02900352

Zonisamide Treatment of Addiction: an Evaluation of Efficacy and Mechanism of Action

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Farmington

AddictionDrugFrom 21 Years to 70 Years

Countries: United States
Sponsor: Virginia Commonwealth University
Condition: Addiction

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.